Exor N.V. — Quarter-over-Quarter 13F Allocation Shifts Q1 2026
In Q1 2026, Exor N.V. . The fund's 13F equity book declined from $5.58B to $5.38B (-3.5% QoQ) . All deltas are sourced from sequential SEC Form 13F-HR filings; share-count changes reflect explicit trading activity, while weight changes can also include price movement. This page lists every position change reported — the portfolio overview shows a summary of the top shifts.
Net Portfolio Value Change
- $5.58BPrior quarter
- $5.38BCurrent quarter
- $-0.19BNet delta
- -3.5%% change
Methodology & FAQ
How Exor N.V. Quarterly Changes Are Computed
Each row above is computed by joining the most recent 13F-HR filing for Exor N.V. against the immediately preceding quarterly filing for the same fund. Portfolio weights are normalized to exclude listed options for comparability. A complete description of the methodology — including how confidential treatment filings are handled and why share count rather than weight is the cleaner trading signal — is documented in the Methodology.
Which positions did Exor N.V. initiate in Q1 2026?
Exor N.V. established no new positions in Q1 2026.
Which existing positions saw the largest allocation increases for Exor N.V. in Q1 2026?
Exor N.V. reported no material allocation increases in existing positions in Q1 2026.
Which positions did Exor N.V. fully exit in Q1 2026?
Exor N.V. fully exited no positions in Q1 2026.
Which existing positions saw the largest allocation reductions for Exor N.V. in Q1 2026?
Exor N.V. reported no material allocation reductions in existing positions in Q1 2026.
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity.